Skip to main content

Table 3 Univariate and multivariate analysis of overall survival in PDAC patients without T2DM

From: Reduced mean platelet volume levels predict shorter survival in patients with resectable pancreatic ductal adenocarcinoma and type 2 diabetes

VariablesUnivariate analysisMultivariate analysis
HR (95% CI)P-valueHR (95% CI)P-value
Age (years) (>  60 versus ≤60)1.139 (0.967–1.343)0.120  
Gender (Male versus Female)1.022 (0.864–1.207)0.802  
BMI (kg/m2)0.985 (0.961–1.010)0.239  
Smoking status (Yes versus No)0.941 (0.792–1.118)0.489  
Drinking status (Yes versus No)1.001 (0.812–1.234)0.993  
FPG (mmol/L) (log-value)1.273 (0.750–2.160)0.371  
Albumin (g/L)1.002 (0.989–1.015)0.767  
Hemoglobin (g/dl)1.003 (0.998–1.007)0.234  
WBC (×109/L)0.995 (0.996–1.026)0.756  
Platelet count (× 109/L)0.999 (0.998–1.000)0.0710.999 (0.998–1.001)0.131
MPV (fL) (≤ 10.0 versus > 10.0)1.183 (0.907–1.542)0.216  
CA19–9 (IU/mL)
 (≤ 37 versus > 37)1.843 (1.488–2.284)<  0.0011.757 (1.408–2.193)<  0.001
Tumor location
 (Head versus Body, tail)1.208 (1.020–1.431)0.0281.095 (0.915–1.311)0.322
Tumor differentiation
 (Poor versus Well/ moderate)1.709 (1.324–2.206)<  0.0011.809 (1.400–2.337)<  0.001
Tumor size (cm)
 (>  4 versus ≤4)1.302 (1.051–1.613)0.0161.229 (0.992–1.523)0.059
Regional lymph node metastasis
 (N1 + N2 versus N0)1.285 (1.060–1.559)0.0111.239 (1.021–1.504)0.030
Chemotherapy (Yes versus No)0.800 (0.679–0.943)0.0080.774 (0.654–0.916)0.003
  1. Abbreviations: see to Table 1